Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Montag, Christiane
Brockmann, Eva-Maria
Lehmann, Anja
Müller, Daniel J.
Rujescu, Dan
Gallinat, Jürgen
and
Reif, Andreas
2012.
Association between Oxytocin Receptor Gene Polymorphisms and Self-Rated ‘Empathic Concern’ in Schizophrenia.
PLoS ONE,
Vol. 7,
Issue. 12,
p.
e51882.
Neumann, Inga D.
and
Landgraf, Rainer
2012.
Balance of brain oxytocin and vasopressin: implications for anxiety, depression, and social behaviors.
Trends in Neurosciences,
Vol. 35,
Issue. 11,
p.
649.
de Lacy, Nina
and
King, Bryan H.
2013.
Revisiting the Relationship Between Autism and Schizophrenia: Toward an Integrated Neurobiology.
Annual Review of Clinical Psychology,
Vol. 9,
Issue. 1,
p.
555.
Cochran, David M.
Fallon, Daniel
Hill, Michael
and
Frazier, Jean A.
2013.
The Role of Oxytocin in Psychiatric Disorders.
Harvard Review of Psychiatry,
Vol. 21,
Issue. 5,
p.
219.
Janicak, Philip G.
2013.
Novel Approaches for Managing Schizophrenia.
Psychopharm Review,
Vol. 48,
Issue. 9,
p.
65.
Koh, Hae-Young
2013.
Phospholipase C-β1 and schizophrenia-related behaviors.
Advances in Biological Regulation,
Vol. 53,
Issue. 3,
p.
242.
Stavropoulos, Katherine K. M.
and
Carver, Leslie J.
2013.
Research Review: Social motivation and oxytocin in autism – implications for joint attention development and intervention.
Journal of Child Psychology and Psychiatry,
Vol. 54,
Issue. 6,
p.
603.
Argiolas, Antonio
and
Melis, Maria Rosaria
2013.
Neuropeptides and central control of sexual behaviour from the past to the present: A review.
Progress in Neurobiology,
Vol. 108,
Issue. ,
p.
80.
Ślusarz, Magdalena J.
Sikorska, Emilia
and
Ślusarz, Rafał
2013.
Interactions of vasopressin and oxytocin receptors with vasopressin analogues substituted in position 2 with 3,3′‐diphenylalanine – a molecular docking study.
Journal of Peptide Science,
Vol. 19,
Issue. 2,
p.
118.
Walss-Bass, Consuelo
Fernandes, João M.
Roberts, David L.
Service, Helena
and
Velligan, Dawn
2013.
Differential correlations between plasma oxytocin and social cognitive capacity and bias in schizophrenia.
Schizophrenia Research,
Vol. 147,
Issue. 2-3,
p.
387.
Seeman, Mary V
2013.
Women and schizophrenia: new findings.
Neuropsychiatry,
Vol. 3,
Issue. 4,
p.
423.
Gannon, Robert L.
2014.
Non-peptide oxytocin receptor ligands and hamster circadian wheel running rhythms.
Brain Research,
Vol. 1585,
Issue. ,
p.
184.
Feifel, David
and
MacDonald, Kai
2014.
Encyclopedia of Psychopharmacology.
p.
1.
Ramsey, Mary E.
Vu, Wendy
and
Cummings, Molly E.
2014.
Testing synaptic plasticity in dynamic mate choice decisions:
N
-methyl
d
-aspartate receptor blockade disrupts female preference
.
Proceedings of the Royal Society B: Biological Sciences,
Vol. 281,
Issue. 1785,
p.
20140047.
Gumley, Andrew
Braehler, Christine
and
Macbeth, Angus
2014.
Retracted: A meta‐analysis and theoretical critique of oxytocin and psychosis: Prospects for attachment and compassion in promoting recovery.
British Journal of Clinical Psychology,
Vol. 53,
Issue. 1,
p.
42.
Javitt, Daniel C.
2014.
Current and Emergent Treatments for Symptoms and Neurocognitive Impairment in Schizophrenia.
Current Treatment Options in Psychiatry,
Vol. 1,
Issue. 2,
p.
107.
Abed, R. T.
and
Abbas, M. J.
2014.
Can the new epidemiology of schizophrenia help elucidate its causation?.
Irish Journal of Psychological Medicine,
Vol. 31,
Issue. 1,
p.
1.
Janicak, Philip G.
2014.
Schizophrenia.
p.
107.
Davis, Michael C.
Horan, William P.
Nurmi, Erika L.
Rizzo, Shemra
Li, Wendy
Sugar, Catherine A.
and
Green, Michael F.
2014.
Associations between oxytocin receptor genotypes and social cognitive performance in individuals with schizophrenia.
Schizophrenia Research,
Vol. 159,
Issue. 2-3,
p.
353.
Klein, Corinna
and
Bespalov, Anton
2014.
Development of novel therapy of schizophrenia in children and adolescents.
Expert Opinion on Investigational Drugs,
Vol. 23,
Issue. 11,
p.
1531.